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ABSTRACT – Background and Objectives: Lifespan is getting longer at a global level.
More people, therefore, live past 65 years of age. Ageing favors frailty, a condition that makes
the body more susceptible to diseases. We present updated information of the European Inno-
vation Partnership on Active and Healthy Ageing (EIP on AHA), and particularly, the Cogni-
tive Decline (CD) group in Action Group 3 (A3), focused in the prevention of frailty and func-
tional decline. Moreover, details of one of the commitments in CD, which deals with the
specificities of women in frailty and ageing (Chronic Ailment Reduction after Menopause,
CARMEN), will be presented as well. Objectives of EIPAHA are to increase life expectancy
of European citizens in two years by 2020 and to improve their quality of life.
Methods: We revised literature and the web of the European Commission in what refers
to EIP on AHA, A3 action group, and CD. Furthermore, we have summarized the main as-
pects of the CARMEN commitment.
Results: We have sketched the main traits of the selected targets. A series of measures
has been taken for favoring prevention of frailty and for health promotion of elderly peo-
ple; this will help to increase the Europeans average healthy lifespan by two years under
conditions of improved quality of life.
Conclusions: A new awareness of the need for prevention of frailty and cognitive de-
cline is extending. Early diagnosis of frailty and functional decline are considered as ef-
fective measures against age-related comorbidities.
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Introduction
According to 2013 data from the World
Health Organization (WHO) life expectancy
is 80 years for women and 73 for men in the
European Union (UE)1. This phenomenon
has led at present to a total of 85 million Eu-
ropean people over 65 years. It is thought that
by 2060 this number will be doubled, ac-
counting for a total of 151 million people2.
This huge progress in longevity would be
blurred if it is not accompanied by improved
standards of health and quality of life (QoL).
Ageing involves physiological decline, which
compromises the response to abrupt changes
in health conditions. Consequently old peo-
ple are more susceptible to suffer diseases,
with cancer, diabetes, cognitive decline (CD)
or Parkinson being particularly prevalent. In
that way the new challenge of overcoming
those situations and of improving patient’s
QoL has emerged.
Frailty can be defined as the inability of an
individual to return to their baseline home-
ostasis after an insult to the body, or a mea-
sure of resilience which increases individ-
ual’s vulnerability for developing increased
dependency and/or mortality when exposed
to a stressor3. Frailty seems to be strongly as-
sociated with some chronic diseases, includ-
ing cardiovascular and pulmonary diseases
and diabetes4. It has been recognized that
frailty may have a biologic basis, with a phys-
ical, social and psychological component5,
but a standardized definition has not yet been
established. Not only physical and cognitive
status but also depression, anxiety and lone-
liness may be a sign of frailty. Depending on
the definition selected, the estimates of frailty
oscillate from 4% to 17%6. There is scientific
consensus in that both the high prevalence
and the impact on health recommend screen-
ing for frailty at population level7. Of inter-
est, the impact of ageing is malleable, and ac-
cordingly, also is frailty, which is seen as a
continuum, where a pre-frail state has been
identified. Lifestyle and other interventions
may help to slow the ageing toll.
There is no consensus about how to screen
for frailty, or about its measurement. The
popular biological index requires that three or
more of the following criteria are present:
weight loss, exhaustion, low activity, slow-
ness and weakness4. It is thought that early
intervention can be effective in stopping or
delaying progression of the process and, con-
sequently, in improving QoL.
Indeed, the attention towards frailty has
been the driver for initiatives aiming at the
modification of health-care systems. A chan -
ge from an organization around single-system
illnesses towards a more holistic viewpoint of
the patient, involving integrated health and
social interventions, would result.
European Innovation
Partnership on Active and
Healthy Ageing (EIP on AHA)
The European Commission (EC) has is-
sued the European Union Strategy, which
pursues the facilitation of the conversion of
innovative ideas into products and services.
One key action has consisted of the European
partnerships. The European Innovation pub-
lic-private Partnerships (PPPs) combine the
resources of governments with those of other
agents like academia, research, industry, pa-
tient organizations and social health providers
in order to deliver societal goals.
As previously commented at a global level,
also the European population is ageing
rapidly, but living longer does not necessar-
ily mean living healthier, more active and
independent. The awareness of this challenge
has moved to the creation of specific part-
nerships. One first pilot of these PPP was
the European Innovation Partnership on Ac-
tive and Healthy Ageing (EIP on AHA) on
20128. Since then, almost 600 commitments
have been submitted by an array of stake-
holders involving more than 3,000 partners.
This partnership aims at identifying and re-
moving persisting barriers to innovation for
active and healthy ageing, through interdis-
ciplinary and cross-sector approaches.
The EC aims at achieving a triple win
through EIP on AHA: (i) enabling EU citizens
to reach healthy, active and independent lives
while ageing; (ii) improving the sustainabil-
ity and efficiency of social and health care
systems; and (iii) boosting and improving the
competitiveness of the markets for innovative
products and services, responding to the age-
ing challenge at both EU and global level,
thus creating new opportunities for business.
Specific objectives in EIP on AHA are to
increase life expectancy of European citizens
in two years and improve their QoL by 2020.
For that purpose, three priority areas have
been established: (i) Prevention, screening
and early diagnosis, (ii) Care and cure and (iii)
Active ageing and independent living. Five
steps were defined in order to reach this ob-
jective including building a database of Good
Practices, assessment of viability of good
practices for scaling up, classification of good
practices for replication, facilitating partner-
ships for scaling up and implementation.
The compilation of Good Practices col-
lects innovative initiatives across EU in the ar-
eas of prescription adherence action at re-
gional level, prevention of functional decline
and frailty, integrated care, independent living
and age-friendly environments9. Good Prac-
tices integrate into action groups. An Action
Group is an assembly of partners committing
to work on a number of actions related to
ageing. Six different action groups have been
defined in EIP on AHA. All of them, sum-
marized in Table 1, have defined their corre-
sponding action plans.
Much of the advancement in the Action
Groups has concentrated in promoting ex-
change for speeding up progression. The par-
ticular initiatives have substantiated into the
introduction of common tasks, as activities in
addition to the particular commitments. Also,
a platform for facilitating contact between
groups has been introduced (Yammer, https://
www.yammer.com/), and group meetings
with responsible Commission officers and
annual conferences are organized regularly.
There are also specific inter-Groups activi-
ties, where topics like synergies, develop-
ment of a common repository, etc., have been
the matter for crossed discussions.
Action plan A3 – Cognitive
decline and frailty
The purpose of the A3 Action Group is the
prevention, early diagnosis and management
of frailty and of functional decline, both
physical and cognitive, in older people. For
that reason A3 includes strategies to screen
for physical, cognitive, psychological and
functional states related to development of
frailty10. In what regards to prevention, some
programs have focused on physical activity
and nutrition as lifestyle measures.
Booklets integrating good practices in ac-
tion groups have been prepared, and so has
been the case in A3. The purpose was to have
a clearer picture of on-going interventions to
prevent frailty. The final text gathers 98 good
practices coming from 14 Member States,
which includes: Belgium, Cyprus, France,
Germany, Greece, Ireland, Italy, Poland, Por-
tugal, Romania, Spain, Sweden, The Nether-
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lands and United Kingdom. Table 2 shows in-
tegrated care good practices taking part in
Action Group A3 by countries.
The implication of the EC in the promotion
of EIP on AHA has included specific funding
within the Calls of the research programme.
For example, the Consumers, Health, Agricul-
ture and Food Executive Agency (CHAFEA) is
funding several research projects. One of
them is the Frailty management Optimisation
though EIP AHA Commitments and Utilisa-
tion of Stakeholders input (FOCUS). The
purpose of FOCUS is to critically reduce the
burden of frailty in Europe by assisting those
partners within the European Innovation Part-
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Table 1
Action Plans concerning EIP on AHA.
Name Description and subgroups
A1 Finding innovative ways to ensure that patients follow their prescriptions and treatments.
Finding innovative solutions to better manage our own health and prevent falls.
• Data and evidence: research
• Implementation: evidence based standards, best practice guidelines and toolkits
• Governance: support, sharing, scaling up and sustainability
Helping to prevent functional decline and frailty.
• Frailty and Functional decline
• Cognitive decline
• Nutrition
• Dependency and caregivers
• Physical activity
Promoting integrated care models for chronic diseases, including the use of remote monitoring.
• Organizational Models
• Change management
• Workforce development
• Risk stratification
• Care pathways
• Patient/user empowerment
Deploying solutions to help older people stay independent and more active for longer.
• Management and coordination
• Collating and sharing practice
• Analysis, guidelines and recommendations
• Promotion and dissemination
Promoting innovation for age-friendly and accessible buildings, cities and environments.
• Implementing Policies and Practices for Regions, Cities and Communities
• Networks promoting an EU Covenant on Demographic Change
• The Spatial Context
• ICT and Smart Environments
A2
A3
B3
D4
C2
nership for Active Healthy Ageing (EIPAHA)
with commitments focusing on early diag-
nosis/screening and/or management of frailty
to achieve scalability.
The project offers both a service and a net -
work. The service consists of evidence-based
guidelines to critically help the selected
group of partners to satisfactorily achieve
their goals. The network intends to prolong
the service in the long term.
To achieve that purpose FOCUS will de-
fine the roadmap, in that it will i) describe the
state of art (review of the scientific literature),
ii) get a picture of the status of the affected
commitments within EIP on AHA (barriers,
enablers, etc.), and iii) obtain information of
the needs of stakeholders. With this real-
world landscape in hand, FOCUS will define
indicators and use a scientifically sound
method, comparative effectiveness research,
to draw conclusions regarding the most ade-
quate and customized approach to assist com-
mitments in achieving success. Inequalities,
cultural conditions or cross-border issues will
be considered as representative of the diver-
sity in Europe. Guidelines and toolkits will be
issued with the perspective of sustainability.
Moreover, FOCUS will constitute the “Plat-
form for Knowledge Exchange” (PKE),
which will both facilitate and perpetuate ex-
change between partners and stakeholders to
achieve synergies and guide progression. PKE
will act as a repository and as an instrument
for dissemination too. The work package 7
(WP7) will be a practical test to verify the us-
ability and performance of guidelines in real
EIPAHA commitments.
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Table 2
Integrated care good practices by countries.
Country All Good Frailty in Functional Cognitive Nutrition Caregivers & Physical
Practices general Decline Decline dependency exercise
Belgium 2 0 0 0 2 0 0
Cyprus 1 0 0 1 0 0 0
France 2 0 1 1 0 0 0
Germany 1 0 0 0 1 0 0
Greece 2 2 0 0 0 0 0
Ireland 3 1 0 2 0 1 0
Italy 17 7 2 2 3 1 2
Poland 2 2 0 0 0 0 0
Portugal 17 1 2 6 2 3 3
Romania 2 1 0 0 0 1 0
Spain 30 8 5 7 3 6 1
Spain/Poland/Finland 1 1 0 0 0 0 0
Sweden 3 1 0 0 1 1 0
The Netherlands 5 2 0 1 0 1 1
UK 9 4 0 1 3 0 1
Total 98 30 10 21 15 14 8
Cognitive decline (CD) in A3
CD constitutes one subgroup within A3. In-
tegrated by some thirty different partners, CD
is developing a series of common tasks, which
add to the respective individual commitments
of the partners11. Important tasks constitute
the initiative to update conceptual aspects, as
reflected by a series of articles already pub-
lished12 or submitted; the integration of data-
bases, the pilot use of ICT (Information and
Communication Technology) based serious
games to screen for frailty and CD, etc.
An important interest within cognitive de-
cline has focused in cognitive frailty. The
reason is the certainty that, as other organs,
brain also suffers from the exhaustion asso-
ciated with ageing. In support of that, both
crossed and longitudinal studies have de-
tected a correlation between physical frailty
and cognitive deterioration. This is why a re-
cent consensus has defined cognitive frailty,
which results by the concurrence of physical
frailty with potentially reversible cognitive
impairment13. Importantly, individuals with
confirmed Alzheimer’s or other dementias
are excluded from the definition.
The impact of gender
One important issue concerns the contrast
between men and women when considering
different dimensions. This has been con-
firmed, for example, for life expectancy (LE)
and healthy-life years (HLY)14. Also, the
QoL of women is compromised, especially
after menopause. Hormonal levels and age
make them more susceptible to diseases like
osteoporosis or cardiovascular disease. The
growing sensitivity to this scenario in both
population and health professionals has fa-
vored an exaggerated administration of drugs
for chronic disease prevention.
The Chronic Ailment Reduction after ME -
Nopause (CARMEN) cohort is one commit-
ment within CD that includes 1,200 elderly
women, which have been followed since
2008. CARMEN includes clinical and ana-
lytical data about community-living women
from the urban area of Valencia. Among the
initiatives of CARMEN, there is a protocol
capable of integrating data about frailty, phy -
sical and cognitive status at screening. There
is also one intervention measure consisting of
the implementation of physical activity to as-
sess the impact on physical and psychological
health. Details of this commitment can be
obtained on the Good Practices Guide9. As a
relevant issue, women are being introduced
into the use of information and communica-
tion technologies (ICT) to increase compliance
with physical activity. In order to screen for
psychological and cognitive frailty some tests
are being applied: Adeenbrooke’s Cognitive
Examination (ACE), Hospitality Anxiety and
Depression Scale (HADS) and an Index of
deficits. Questions regarding loneliness, tem-
poral orientation, social relationship or emo-
tional and intellectual activity are also inte-
grated in the protocol.
Conclusion
and Future directions
The EC has developed EIPonAHA with
the purpose of implementing new strategies
to improve the prevention and early diagno-
sis of frailty and diseases related to age. The
challenge is to ensure that people not only
live longer, but also healthier and more active.
EIP on AHA is structured into six Action
Groups with different perspectives. In the
present report we have concentrated on A3,
the group focused on frailty and cognitive de-
cline. A3 includes 98 good practices. It is
believed that lifestyle, including physical ac-
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tivity and diet, is one good measure for pre-
venting the disorders associated with age.
The scalability of good practices, together
with expansion of research in effective inter-
ventions, should increase the benefits in
terms of healthy longevity.
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